Ivermectin and malaria control

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Omura, Satoshi ^a   Crump, Andy ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Feed through insecticide; Ivermectin; Malaria

Indexed keywords

ANTHELMINTIC AGENT; INSECTICIDE; IVERMECTIN; PYRETHROID; ANTIMALARIAL AGENT;

ANOPHELES; COMMUNITY PROGRAM; DISEASE ELIMINATION; DRUG REPOSITIONING; DRUG SOLUBILITY; HELMINTHIASIS; HUMAN; LYMPHATIC FILARIASIS; MALARIA; MALARIA CONTROL; MAXIMUM PLASMA CONCENTRATION; MORTALITY RATE; NEGLECTED DISEASE; NONHUMAN; ONCHOCERCIASIS; PEDICULOSIS CAPITIS; PLASMA HALF LIFE; PUBLIC HEALTH PROBLEM; REVIEW; SCABIES; SCHISTOSOMIASIS; SOCIOECONOMICS; STRONGYLOIDIASIS; TRACHOMA; VECTOR CONTROL; CHEMISTRY; STRUCTURE ACTIVITY RELATION; TROPICAL MEDICINE;

ANTIMALARIALS; HUMANS; IVERMECTIN; MALARIA; NEGLECTED DISEASES; STRUCTURE-ACTIVITY RELATIONSHIP; TROPICAL MEDICINE;

EID: 85018606088     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1825-9     Document Type: Review

References (20)

1. Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J. 2017. doi: 10.1186/s12936-017-1801-4.
2. Chaccour CJ, Rabinovich NR. Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway. Malar J. 2017. doi: 10.1186/s12936-017-1802-3.
3. Chaccour CJ, Rabinovich NR. Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways. Malar J. 2017. doi: 10.1186/s12936-017-1803-2.
4. Omura S, Crump A. The life and times of ivermectin: a success story. Nat Rev Microbiol. 2005;2:984-9.
5. WHO. Update on the global status of implementation of preventive chemotherapy. (PC); 8th March 2017. Accessed 9 Mar 2017.
6. ESPEN. http://www.afro.who.int/en/espen/about.html. Accessed 19 Apr 2017.
7. Tesh RB, Guzman H. Mortality and infertility in adult mosquitoes after the ingestion of blood containing ivermectin. Am J Trop Med Hyg. 1990;43:229-33.
8. Chaccour C, Lines J, Whitty CJM. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans; the potential of oral insecticides in malaria control. J Infect Dis. 2010;202:113-6.
9. Kobylinski KC, Deus KM, Butters MP, Hongyu T, Gray M, da Silva IM, et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop. 2010;116:119-26.
10. Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD. Ivermectin mass drug administration for humans disrupts malaria parasite transmission in Senegalese villages. Am J Trop Med Hyg. 2011;85:3-5.
11. Foy BD, Kobylinski KC, da Silva IM, Rasgon JL, Sylla M. Endectocides for malaria control. Trends Parasitol. 2011;27:423-8.
12. Panchal M, Rawat K, Kumar G, Kibria KM, Singh S, Kalamuddin M, et al. Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP. Cell Death Dis. 2014;16:e994.
13. Chaccour CJ, Rabinovich NR, Slater H, Canavati SE, Bousema T, Lacerda M, et al. Establishment of the ivermectin research for malaria elimination network: updating the research agenda. Malar J. 2015;14:243.
14. Crump A. Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations. J Antibiot. 2017. doi: 10.1038/ja.2017.11 (Epub ahead of print).
15. Campbell WC. Ivermectin: an update. Parasitol Today. 1985;1:10-6.
16. Katz N, Araújo N, Coelho PM, Morel CM, Linde-Arias AR, Yamada T, et al. Ivermectin efficacy against Biomphalaria, intermediate host snail vectors of Schistosomiasis. J Antibiot. 2017. doi: 10.1038/ja.2017.31 (Epub ahead of print).
17. Fink DW, Porras AG. Pharmacokinetics of ivermectin in animals and humans. In: Campbell WC, editor. Ivermectin and abamectin. Springer: New York; 1989. p. 113-30.
18. Baraka OZ, Mahmoud BM, Marschke CK, Geary TG, Homeida MM, Williams JF. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur J Clin Pharmacol. 1996;50:407-10.
19. González Canga A, Sahagún Prieto AM, Diez Liébana MJ, Fernández Martínez N, Sierra Vega M, García Vieitez JJ. The pharmacokinetics and interactions of ivermectin in humans - a mini-review. AAPS J. 2008;10:42-6.
20. WHO. Global technical strategy for malaria 2016-2030. Geneva: World Health Organization; 2015. http://www.who.int/malaria/areas/global-technical